Business · 12/05/2006

HRSA and FDA Amend Regulations to Include Blood Vessels Recovered with Organs in Organ Transplantation

The Health Resources and Services Administration (HRSA) and the Food and Drug Administration (FDA) are updating their rules to consider blood vessels recovered with organs for use in organ transplantation, while excluding them from the definition of human cells, tissues, and cellular and tissue-based products.